Brief: Karyopharm Announces Completion Of Enrollment In The Phase 3 Sentry Trial In Myelofibrosis
10/09/2025 12:50
Sept 10 (Reuters) - Karyopharm Therapeutics Inc KPTI.O: KARYOPHARM ANNOUNCES COMPLETION OF ENROLLMENT IN THE PHASE 3 SENTRY TRIAL IN MYELOFIBROSIS KARYOPHARM THERAPEUTICS INC - TOP-LINE RESULTS EXPECTED IN FIRST HALF OF 2026 Source text: ID:nPn2NJvLRa Further company coverage: KPTI.O ((Reuters.Briefs@thomsonreuters.com;))